Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
AbstractAdenosine diphosphate (ADP) is the major platelet agonist, which is important in the shape changes, stability, and growth of the thrombus. Platelet activation by ADP is associated with the G protein-coupled receptors P2Y1 and P2Y12. The pharmacologic blockade of the P2Y12 receptor significantly reduces the risk of peripheral artery disease, myocardial infarction, ischemic stroke, and vascular death. Recent studies demonstrated the inhibition of ADP-induced blood platelet activation by three major compounds of the flavonolignans group: silybin, silychristin, and silydianin. For this reason, the aim of the current work was to verify the effects of silybin, silychristin, and silydianin on ADP-induced physiological platelets responses, as well as mechanisms of P2Y12-dependent intracellular signal transduction. We evaluated the effect of tested flavonolignans on ADP-induced blood platelets’ aggregation in platelet-rich plasma (PRP) (using light transmission aggregometry), adhesion to fibrinogen (using the static method), and the secretion of PF-4 (using the ELISA method). Additionally, using the double labeled flow cytometry method, we estimated platelet vasodilator-stimulated phosphoprotein (VASP) phosphorylation. We demonstrated a dose-dependent reduction of blood platelets’ ability to perform ADP-induced aggregation, adhere to fibrinogen, and secrete PF-4 in samples treated with flavonolignans. Additionally, we observed that all of the tested flavonolignans were able to increase VASP phosphorylation in blood platelets samples, which is correlated with P2Y12 receptor inhibition. All of these analyses show that silychristin and silybin have the strongest inhibitory effect on blood platelet activation by ADP, while silydianin also inhibits the ADP pathway, but to a lesser extent. The results obtained in this study clearly demonstrate that silybin, silychristin, and silydianin have inhibitory properties against the P2Y12 receptor and block ADP-induced blood platelet activation. View Full-Text
Share & Cite This Article
Bijak, M.; Szelenberger, R.; Dziedzic, A.; Saluk-Bijak, J. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets. Molecules 2018, 23, 374.
Bijak M, Szelenberger R, Dziedzic A, Saluk-Bijak J. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets. Molecules. 2018; 23(2):374.Chicago/Turabian Style
Bijak, Michal; Szelenberger, Rafal; Dziedzic, Angela; Saluk-Bijak, Joanna. 2018. "Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets." Molecules 23, no. 2: 374.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.